A detailed history of Cornerstone Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 22,900 shares of AMGN stock, worth $7.24 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
22,900
Previous 23,100 0.87%
Holding current value
$7.24 Million
Previous $6.57 Million 8.95%
% of portfolio
0.29%
Previous 0.27%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $52,550 - $63,862
-200 Reduced 0.87%
22,900 $7.16 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $80,661 - $97,368
300 Added 1.32%
23,100 $6.57 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $409,120 - $461,535
-1,600 Reduced 6.56%
22,800 $6.57 Million
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $830,870 - $1.03 Million
3,800 Added 18.45%
24,400 $6.56 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $4.41 Million - $5.22 Million
20,600 New
20,600 $4.57 Million
Q4 2021

May 11, 2022

SELL
$198.88 - $227.6 $3.38 Million - $3.87 Million
-17,000 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $233,580 - $259,140
-1,000 Reduced 5.56%
17,000 $4.14 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $4.88 Million - $5.69 Million
-22,000 Reduced 55.0%
18,000 $4.48 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $3.05 Million - $3.39 Million
13,000 Added 48.15%
40,000 $10.2 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $5.34 Million - $6.55 Million
27,000 New
27,000 $6.37 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cornerstone Advisors, LLC Portfolio

Follow Cornerstone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.